Korean J Psychopharmacol.
2010 Apr;21(2):99-103.
A Case of Paroxetine-Related Hyperprolactinemia
- Affiliations
-
- 1Department of Psychiatry, Dongnae Bongseng Hospital, Busan, Korea.
- 2Department of Endocrinology, Dongnae Bongseng Hospital, Busan, Korea.
- 3Department of Psychiatry, Bongseng Memorial Hospital, Busan, Korea. npdoctors@naver.com
Abstract
- Although selective serotonin reuptake inhibitors (SSRIs) have been widely used in both psychiatry and other medicine, few cases have been reported SSRI-related hyperprolactinemia and/or galactorrhea. We experienced one case which showed both galactorrhea and hyperprolactinemia following treatment with paroxetine. In the case, a 37-year-old multiparous woman reported galactorrhea after 8-weeks paroxetine treatment for her depression. After 1 month prescription of bromocriptine, dopamine agonist, as well as switching medication from paroxetine to venlafaxine, serotonin-norepinephrine reuptake inhibitor, both galactorrhea and hyperprolactinemia were disappeared. Both hyperprolactinemia and galactorrhea have not been observed even after the cessation of bromocriptine prescription.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A case of syndrome of inappropriate secretion of antidiuretic hormone associated with paroxetine
- Clinical approach of Hyperprolactinemia
- Mirtazapine in Paroxetine Induced Hyper-prolactinemic Galactorrhoea
- Different Responses of Aripiprazole Combination Treatment in Antipsychotics-Induced Hyperprolactinemia: 2 Cases
- Worsening of Migraine Associated with Hyperprolactinemia
